The FDA clarified Thursday that it won't take action against GLP-1 compounders for certain violations while it reevaluates ...

Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the FDA revisits its decision to remove it.

New research estimates that expanded access to Ozempic and similar drugs could lead to 42,000 deaths prevented annually.

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down ...

We spoke with Dr. Demetre Daskalakis, the director of the CDC’s National Center for Immunization and Respiratory Diseases, about the agency’s avian flu response.

A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the ...

Only 15% of those who start a glucagon-like peptide 1 (GLP-1) for weight loss are still taking it two years according to ...

The British government believes weight-loss drugs could play a role in its push to reduce the number of long-term unemployed ...

GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...

Gluco6 is a cutting-edge supplement designed to optimize blood sugar regulation and alleviate nerve pain. Its unique f ...

Expanding access to new, highly effective weight-loss medications could prevent more than 40,000 deaths a year in the United ...

Millions of Americans rely on a new class of medications to manage chronic conditions like diabetes and obesity, with ...